10-Benzoyl-1,8-dihydroxy-9(10H)-anthracenones: Synthesis and biological properties

European Journal of Medicinal Chemistry

Volumn 33, Issue 3, 1998, Pages 209-214

  Müller, Klaus ^a   Altmann, Reinhold ^b   Prinz, Helge ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

5 Lipoxygenase; Anthracenone; Anthralin; Antiproliferative activity; Dithranol; HaCaT; Hydroxyl radical

Indexed keywords

10 BENZOYL 1,8 DIHYDROXY 9(10H) ANTHRACENONE; ANTIMITOTIC AGENT; ANTIPSORIASIS AGENT; DITHRANOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATTLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; NEUTROPHIL; NONHUMAN; PHASE CONTRAST MICROSCOPY;

EID: 0032033703     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80010-X     Document Type: Article

References (22)

1. [1] Kemény L., Ruzicka T., Braun-Falco O., Skin Pharmacol. 3 (1990) 1-20.
2. [2] Müller K., Gen. Pharmacol. 27 (1996) 1325-1335.
3. [3] Müller K., Biochem. Pharmacol. 53 (1997) 1215-1221.
4. [4] Müller K., Gürster D., Piwek S., Wiegrebe W., J. Med. Chem. 36 (1993) 4099-4107.
5. [5] Pecar S., Schara M., Müller K., Wiegrebe W., Free Radical Biol. Med. 18 (1995) 459-465.
6. [6] Berset J.-D., Krebs A., Pharm. Acta Helv. 65 (1990) 14-19.
7. [7] Prinz H., Wiegrebe W., Müller K., J. Org. Chem. 61 (1996) 2861-2864.
8. [8] Müller K., Sellmer A., Prinz H., Eur. J. Med. Chem. 32 (1997) 895-900.
9. [9] Ford-Hutchinson A.W., Potential and therapeutical value of development of novel 5-lipoxygenase inhibitors, in: Cooke S.T., Wong A. (Eds.), Lipoxygenases and Their Products, Academic Press, London, 1991, pp. 137-160.
10. [10] Müller K., Arch. Pharm. (Weinheim) 327 (1994) 3-19.
11. [11] Müller K., Leukel P., Ziereis K., Gawlik I., J. Med. Chem. 37 (1994) 1660-1669.
12. [12] Bonnekoh B., Farkas B., Geisel J., Mahrle G., Arch. Dermatol. Res. 282 (1990) 325-329.
13. [13] Halliwell B., Grootveld M., Gutteridge J.M.C., Methods Biochem. Anal. 33 (1988) 59-90.
14. [14] Hofer P., Ott R., Pharm. Acta Helv. 49 (1974) 35-37.
15. [15] Cragg J.E., Herbert R.B., Jackson F.B., Moody C.J., Nicolson I.T., J. Chem. Soc. Perkin Trans. 1 (1982) 2477-2485.
16. [16] Barger G., J. Chem. Soc. 93 (1908) 563-573.
17. [17] Rohmann C., Wischniewski T., Arch. Pharm. (Weinheim) 292 (1959) 787-792.
18. [18] Schönenberger H., Holzheu-Eckardt J., Bamann E., Arzneim. Forsch. 14 (1964) 324-328.
19. [19] Bradley W., Schwarzenbach G., J. Chem. Soc. (1928) 2904-2912.
20. [20] Fischer E., Bergmann M., Lipschitz W., Ber. Dt. Chem. Ges. 51 (1918) 53-73.
21. [21] Cohen J.B., Dudley H.W., J. Chem. Soc. 97 (1910) 1732-1751.
22. [22] Müller K., Gürster D., Biochem. Pharmacol. 46 (1993) 1695-1704.